Literature DB >> 2574716

Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms.

J L Waddington1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2574716     DOI： 10.1016/s0074-7742(08)60282-2

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN： 0074-7742            Impact factor:   3.230


× No keyword cloud information.
  12 in total

1.  Essential conservation of D1 mutant phenotype at the level of individual topographies of behaviour in mice lacking both D1 and D3 dopamine receptors.

Authors:  John Y F Wong; Jeremiah J Clifford; Jim S Massalas; Anthony Kinsella; John L Waddington; John Drago
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

2.  Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal.

Authors:  Ian E J De Souza; Niamh M Dawson; Jeremiah J Clifford; John L Waddington; Gloria E Meredith
Journal:  Psychopharmacology (Berl)       Date:  2003-06-27       Impact factor: 4.530

3.  Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats.

Authors:  O A Andreassen; T O Aamo; H A Jøorgensen
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 4.  Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.

Authors:  J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Movements in never-medicated schizophrenics: a preliminary study.

Authors:  D S Fenn; D Moussaoui; W F Hoffman; N Kadri; B Bentounssi; A Tilane; M Khomeis; D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

6.  Nigella sativa Oil Reduces Extrapyramidal Symptoms (EPS)-Like Behavior in Haloperidol-Treated Rats.

Authors:  Tafheem Malik; Sheema Hasan; Shahid Pervez; Tasneem Fatima; Darakhshan Jabeen Haleem
Journal:  Neurochem Res       Date:  2016-10-18       Impact factor: 3.996

7.  Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.

Authors:  Stefan Gebhardt; Fabian Härtling; Markus Hanke; Frank M Theisen; Richard von Georgi; Phillip Grant; Markus Mittendorf; Matthias Martin; Christian Fleischhaker; Eberhard Schulz; Helmut Remschmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

8.  GM1 ganglioside attenuates the development of vacuous chewing movements induced by long-term haloperidol treatment of rats.

Authors:  O A Andreassen; H A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

Review 9.  Neurological signs and involuntary movements in schizophrenia: intrinsic to and informative on systems pathobiology.

Authors:  Peter F Whitty; Olabisi Owoeye; John L Waddington
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

10.  Interactions of the subthalamic nucleus and the subpallidal area in oro-facial dyskinesia: role of GABA and glutamate.

Authors:  W P Spooren; S E Helfrich; A R Cools
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.